Exclusive: Neurona bags $102M to treat epilepsy with cell therapynews2025-04-03T10:00:15+00:00April 3rd, 2025|Endpoints News|
Eli Lilly adds obesity startup knownwell to its direct-to-consumer servicenews2025-04-02T16:55:45+00:00April 2nd, 2025|Endpoints News|
Atsena raises $150M to target rare form of blindness with gene therapynews2025-04-02T11:30:59+00:00April 2nd, 2025|Endpoints News|
RNA editing startup AIRNA raises $155M for liver and lung disease therapynews2025-04-01T11:00:16+00:00April 1st, 2025|Endpoints News|
Inspirna, which was preparing for a Phase 3 cancer trial, has foldednews2025-03-31T14:48:46+00:00March 31st, 2025|Endpoints News|
Isomorphic Labs gets $600M from Thrive, GV and Alphabetnews2025-03-31T11:34:13+00:00March 31st, 2025|Endpoints News|
Exclusive: SV Health debuts Parkinson’s biotech with backing from AbbVie and othersnews2025-03-31T04:01:20+00:00March 31st, 2025|Endpoints News|
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025news2025-03-27T17:51:01+00:00March 27th, 2025|Endpoints News|
Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicinesnews2025-03-27T11:00:18+00:00March 27th, 2025|Endpoints News|
Alcon takes majority stake in Aurion, changes CEOsnews2025-03-27T01:24:07+00:00March 27th, 2025|Endpoints News|
